Ligand validation:3SL6

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3SL6_EPE_C_2	30%	29%	0.263	0.927	1.04	1.77	1	6	2	0	100%	1
7AAG_EPE_C_514	83%	12%	0.113	0.973	2.46	1.68	1	4	0	0	100%	1
7ABE_EPE_C_509	81%	11%	0.127	0.981	2.07	2.07	2	4	0	0	100%	1
6FET_EPE_B_507	80%	21%	0.112	0.961	1.25	2.07	1	5	0	0	100%	1
6FW3_EPE_D_516	80%	6%	0.125	0.973	3.23	1.98	4	5	1	0	100%	1
6HWO_EPE_C_503	76%	2%	0.133	0.971	1.81	5.19	2	7	0	0	100%	1
1XX1_EPE_C_2003	100%	37%	0.024	0.996	0.73	1.72	1	4	1	0	100%	1
3EC7_EPE_E_401	100%	10%	0.031	0.993	1.1	3.18	1	11	1	0	100%	1
2BDU_EPE_B_402	100%	29%	0.033	0.993	0.87	1.95	1	5	0	0	100%	1
8XBN_EPE_A_301	99%	69%	0.05	0.985	0.39	0.79	-	-	0	0	100%	1
3R7A_EPE_B_301	99%	39%	0.053	0.987	0.79	1.56	1	4	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.